Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced the successful closure of a $55 million funding round from the company's existing investment ...

Bottom line of study: SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney ...

Initially used for blood glucose control, the medications reduce cardiovascular events and mitigate heart failure ...

For people with advanced heart failure, left ventricular assist devices, or LVADs, can be a literal lifesaver.

Experts say that semaglutide and tirzepatide can help patients with heart failure lose weight, but limited NHS access is ...

SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney disease. However, there ...

A Cardiff-based business working on "revolutionary" new pacemaker technology, aimed at helping patients with long-term heart ...

The FDA has approved a new pill called Widaplik, which combines three drugs – telmisartan, amlodipine, and indapamide – to treat adults who have high blood pressure.

Maury Regional Health (MRH) is now offering an advanced tool for patients with heart failure: the CardioMEMS™ HF System. This ...

Despite incomplete evidence, longevity enthusiasts are experimenting with SGLT2 inhibitors in their quest to live healthier ...

– For people who have heart failure with a normal heart rhythm, there seems to be little to no advantage of warfarin (an anticoagulant: a medicine which prevents blood clotting by blocking proteins) ...